JCM
BIIB icon

Jafra Capital Management’s Biogen BIIB Stock Holding History

Jafra Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-7,500
Closed -$2.39M – 89
2017
Q4 		$2.39M Sell
7,500
-6,272
-46% -$2.01M 0.67% 45
2017
Q3 		$4.31M Buy
13,772
+72
+0.5% +$21.3K 1.61% 24
2017
Q2 		$3.72M Buy
13,700
+7,700
+128% +$2.04M 1.38% 25
2017
Q1 		$1.64M Buy
+6,000
New +$1.7M 0.66% 41

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jafra Capital Management's BIIB Position: Q1 2018 in Review

Jafra Capital Management sold out of Biogen (BIIB) in Q1 2018, closing a stake of 7,500 shares — an estimated $2.39M sold.

Jafra Capital Management first reported a position in BIIB in Q1 2017 and held it in 4 quarters. The position peaked at $4.31M in Q3 2017. 1,102 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

  • Jafra Capital Management reported no remaining Biogen position as of Q1 2018 after selling out during the quarter.
  • Jafra Capital Management sold 7,500 Biogen shares in Q1 2018, an estimated $2.39M.
  • Jafra Capital Management first reported a position in Biogen in Q1 2017 and held it in 4 quarters.
  • Jafra Capital Management's Biogen position peaked at $4.31M in Q3 2017.
  • 1,102 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on Jafra Capital Management's 13F filing for Q1 2018, filed 23 Apr 2018.